Pharmafile Logo

Protheragen

Located in the USA, Protheragen provides a full range of clinical trial consulting, design, conduction, management, reporting and analysis services to advance your clinical trial development. Protheragen continuously provides professional support to local, national and international clients. Our clinical trial services focus on the entire clinical trial lifecycle, including bioanalytical lab testing, clinical pharmacology, first-in-human (FIH), proof of concept (POC), early phase trials, phase IIa trials, phase IIb-III trials, phase IIIb-IV trials, CDM analysis and reporting. We guarantee the confidentiality and sensitivity of our customers’ data.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Holbrook, NY 11741, USA

 Latest Content from PMHub 

Changing the narrative: why hidden struggles matter

Press Releases | September 10, 2026 | Mednet

On Suicide Prevention Day, we’re focusing on something often overlooked: the difference between what’s visible and what’s actually being carried. Many people living with long-term or chronic illness experience challenges...

From Booth to Bavaria: A Recap of Impact at ESC 2026

Press Releases | September 7, 2026 | Medscape Education

We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based...

Supporting the people who support patients

Press Releases | August 28, 2026 | Mednet

Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.

NEW PHARMA-EXCLUSIVE WEBINAR: Beyond the Hype; Practical, Compliant AI Solutions for Pharma Engagement

Press Releases | August 27, 2026 | Impetus Digital

See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

Four steps to a smarter congress strategy: A practical guidebook

This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Real Chemistry Deepens German Market Expertise with Appointment of Dirk Poschenrieder as Managing Director, Germany

Press Releases | August 25, 2026 | Real Chemistry

Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution

Cutting the friction from health comms through whole-person design

Press Releases | August 24, 2026 | Mednet

Good design can’t change the reality of illness, remove the pain, or stop the uncertainty. But it can stop learning what comes next from being another burden to carry.

The Future of Decisioning

Press Releases | August 20, 2026 | Havas Lynx

The traditional model for gathering insights is reaching a breaking point. Healthcare Professionals (HCPs) are increasingly time-poor and difficult to reach. Simultaneously, the costs of traditional market research are rising,...

Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth

Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board